Thrombolytic Control Plasma is prepared from human plasma to simulate plasma from patients treated with streptokinase or urokinase. This lyophilized control plasma contains elevated levels of Fibrinogen Degradation Products (FDP) and decreased levels of fibrinogen plasma from patients in the lytic state.
Net Contents: 5 x 1.0mL
Thrombolytic Control plasma is used as a therapeutic level control in tests for monitoring thrombolytic therapy. When assayed in the same manner as a patient plasma, it serves to verify sensitivity and precision in the critical therapeutic range of test system in use.
ADOBE® READER® is required to view: Product Data Sheets, Technical Bulletins, MSDS Information, Reprints, and News Releases. Download it for free.
